Interview with Dr. Joel Lexchin

Interview with Dr. Joel Lexchin | University of Toronto Medical Journal } Home Archives Vol. 98 No. 3 (2021): Vaccines and Immunity Interviews Main Article Content

Seth Kibel

Abstract

Dr. Joel Lexchin received his MD from the University of Toronto in 1977 and for the past 33 years has been an emergency physician at the University Health Network. He taught healthy policy in the School of Health Policy and Management at York University from 2001 to 2016 and is now a Professor Emeritus at York. He has been a consultant on pharmaceutical issues for the province of Ontario, various arms of the Canadian federal government, the World Health Organization, and the government of New Zealand. He is a frequent outspoken critic of the pharmaceutical industry and the way that Health Canada regulates drugs. His book Private profits versus public policy: the pharmaceutical industry and the Canadian state was published by University of Toronto Press in September 2016 and his new book Doctors in denial: why big pharma and the Canadian medical profession are too close for comfort was published by Lorimer in May 2017. In 2012 he was elected as a Fellow in the Canadian Academy of Health Sciences.

Article Sidebar Article Details

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

留言 (0)

沒有登入
gif